Impact of Structural Features on the Antioxidant Activity of Organofluorine Diaryl Hydrazones
Molecules · 2025
DOI: 10.3390/molecules31010078 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Zsuzsanna K Zsengellér und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Beth Israel Lahey Health, Boston, MA 02115, USA. Hauptthemen laut MEDLINE: Antioxidants, Hydrazones. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, Massachusetts Life Science Center Women's Health Innovation Grant, Peter Joseph Pappas Research Grant Award-Preeclampsia Foundation.
Abstract (Originalsprache)
Preeclampsia (PE) affects 2–8% of pregnancies, yet it lacks curative treatment options. Oxidative stress caused by the release of reactive oxygen and nitrogen species (ROS/RNS) in the placenta is common in abnormal placental development. It can cause downstream signaling and the formation of anti-angiogenic factors, e.g., soluble fms-like tyrosine kinase 1 (sFLT-1), leading to symptoms of PE, such as hypertension, proteinuria, and, in severe cases, eclampsia. Mitochondria-targeted antioxidants were developed to reduce oxidative stress and alleviate PE symptoms. Ten organofluorine diaryl hydrazones were designed as potential antioxidants, synthesized, and tested for their activity using the 2,2-diphenyl-1-picrylhydrazyl (DPPH), 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS), and oxygen radical absorbance capacity (ORAC) assays. Compounds 2, 3, 5, and 6 showed excellent antioxidant capacity in all three assays and were tested in an in vitro human trophoblast cell culture system mimicking PE in which the cells were exposed to oxidative stress inducing the release of sFLT-1. The anti-angiogenic factor sFLT-1 was greatly reduced in cells treated with antioxidants. Compounds 5 and 6 were more effective in preventing sFLT-1 release than 2 and 3. Density functional theory calculations of the electronic structures of compounds 2, 5, and 6 were conducted at the M06-2X/6-311G+(d,p) level to further understand the reactivity profile of these molecules. The electron density of delocalized bonds (EDDB(r)) was calculated to analyze the effect of delocalization on radical stabilization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Beth Israel Lahey Health, Boston, MA 02115, USA.
- Department of Chemistry, University of Massachusetts Boston, Boston, MA 02125, USA.
- Department of OB/GYN, Beth Israel Lahey Health, Boston, MA 02115, USA.
- Department of OB/GYN, Mt Auburn Hospital, Cambridge, MA 02138, USA.
ORCID-Profile: Zsuzsanna K Zsengellér, Bernadett R Vlocskó, Brett C Young, Béla Török, Marianna Török
Förderung
- NICHD NIH HHS
- Massachusetts Life Science Center Women's Health Innovation Grant
- Peter Joseph Pappas Research Grant Award-Preeclampsia Foundation
- Milton Fund-Harvard University
- American Heart Association
- NIH HHS
- Milton Fund—Harvard University
- National Institutes of Health
Zitieren
APA
Zsengellér, Z. K., Mastyugin, M., Fusco, A. R., Vlocskó, B. R., Ferguson, C., Pintye, D., Nasim, H., Salahuddin, S., Young, B. C., Török, B., & Török, M. (2025). Impact of Structural Features on the Antioxidant Activity of Organofluorine Diaryl Hydrazones. Molecules. https://doi.org/10.3390/molecules31010078
Vancouver
Zsengellér ZK, Mastyugin M, Fusco AR, Vlocskó BR, Ferguson C, Pintye D, et al. Impact of Structural Features on the Antioxidant Activity of Organofluorine Diaryl Hydrazones. Molecules. 2025. doi:10.3390/molecules31010078
BibTeX
@article{Zsengellr2025,
author = {Zsengellér, Zsuzsanna K and Mastyugin, Maxim and Fusco, Adrianna R and Vlocskó, Bernadett R and Ferguson, Coryn and Pintye, Diana and Nasim, Hamad and Salahuddin, Saira and Young, Brett C and Török, Béla and Török, Marianna},
title = {Impact of Structural Features on the Antioxidant Activity of Organofluorine Diaryl Hydrazones},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules31010078}
}
EUVIMED